Inuvo, Inc. (INUV) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the INUV SEC filings page.
Inuvo, Inc. (INUV) reported $52.3M in revenue over the twelve months to Jun 30, 2026, down 46.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue now exceeds $86.2M , but thin liquidity and rising leverage leave growth dependent on financing rather than self-funding.
In FY2025, gross margin was74.5% while operating cash flow was-$1.8M , showing that sales still did not translate into cash after delivery costs. That cash result reversed FY2024's positive$230K , making the improvement in reported losses less durable than the income statement alone suggests.
The current ratio fell from 0.9x in FY2024 to 0.6x in FY2025, meaning short-term obligations exceeded current assets at the latest year-end. Debt-to-equity reached 1.5x as total equity fell to
The reported liquidity comparison equaled 19.1 months of the latest annual operating outflow, but FY2025 financing cash flow was
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Inuvo, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Inuvo, Inc. held $2.8M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $1.8M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Inuvo, Inc. scores 45/100 among other emerging companies.
Inuvo, Inc. had 15M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Inuvo, Inc. scores 94/100 among other emerging companies.
Not available for Inuvo, Inc., and counted as zero in the overall score.
Inuvo, Inc. reported revenue of $86.2M in fiscal year 2025, against $83.8M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Inuvo, Inc. scores 53/100 among other emerging companies.
Inuvo, Inc.'s operations used $1.8M of cash in fiscal year 2025, against $230K generated in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Inuvo, Inc. scores 61/100 among other emerging companies.
Inuvo, Inc.'s cash, cash equivalents and investments came to $2.8M at the end of fiscal year 2025, against $14.8M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Inuvo, Inc. scores 26/100 among other emerging companies.
Inuvo, Inc. scores -7.37, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($8.4M) relative to total liabilities ($14.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Inuvo, Inc. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Inuvo, Inc. reported a net loss of $5.1M while operations used $1.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Inuvo, Inc. generated $7.5M in revenue in Q2 2026. This represents a decrease of 66.8% from the same quarter a year earlier. Against the prior quarter it is down 5.0%.
Inuvo, Inc.'s EBITDA was -$2.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 71.1% from the same quarter a year earlier. Against the prior quarter it is up 24.5%.
Inuvo, Inc. reported -$4.0M in net income in Q2 2026. This represents a decrease of 169.1% from the same quarter a year earlier. Against the prior quarter it is down 313.1%.
Inuvo, Inc. earned -$0.27 per diluted share (EPS) in Q2 2026. This represents a decrease of 170.0% from the same quarter a year earlier. Against the prior quarter it is down 307.7%.
Cash & Balance Sheet
Inuvo, Inc. recorded an outflow of $2.5M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 868.0% from the same quarter a year earlier. Against the prior quarter it is down 306.9%.
Inuvo, Inc. held $886K in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Inuvo, Inc.'s gross margin was 44.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 31.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.1 percentage points.
Inuvo, Inc.'s operating margin was -40.4% in Q2 2026, reflecting core business profitability. This is down 31.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.6 percentage points.
Inuvo, Inc.'s net profit margin was -53.6% in Q2 2026, showing the share of revenue converted to profit. This is down 47.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 77.5 percentage points.
Inuvo, Inc.'s ROE was -48.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 36.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 64.1 percentage points.
Capital Allocation
Inuvo, Inc. invested $239K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 41.2% from the same quarter a year earlier. Against the prior quarter it is down 33.3%.
Not reported for Q2 2026.
Not reported for Q2 2026.
INUV Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5M-66.8% | $7.9M-70.3% | $14.3M-45.6% | $22.6M+0.9% | $22.7M+24.5% | $26.7M+56.9% | $26.2M+25.7% | $22.4M-9.0% |
| Cost of Revenue | $4.2M-24.6% | $4.3M+34009.3% | $10.4M+134.6% | $6.0M+131.3% | $5.6M+91.9% | $13K-99.4% | $4.4M+67.7% | $2.6M+14.1% |
| Gross Profit | $3.3M-80.5% | $3.7M-82.6% | $9.5M-56.5% | $16.6M-16.2% | $17.1M+11.7% | $21.1M+41.3% | $21.8M+19.5% | $19.8M-11.3% |
| SG&A Expenses | $2.1M+17.5% | $1.8M+1.0% | $1.7M-2.2% | $1.7M+6.9% | $1.8M+16.9% | $1.7M+153.4% | $1.7M-6.1% | $1.6M-31.2% |
| Operating Income | -$3.0M-48.9% | -$3.9M-119.3% | -$1.2M-651.1% | -$1.7M+14.1% | -$2.0M-20.3% | -$1.8M+15.4% | $220K+109.1% | -$1.9M-63.2% |
| EBITDA | -$2.5M-71.1% | -$3.3M-178.1% | -$670K-188.8% | -$1.1M+16.2% | -$1.5M-46.7% | -$1.2M+15.3% | $754K+157.6% | -$1.3M-77.2% |
| Income Tax | $3K | $3K0.0% | $3K0.0% | $5K | $0-100.0% | $3K | $3K | $0 |
| Net Income | -$4.0M-169.1% | $1.9M+250.5% | -$594K-520.2% | -$1.7M+14.9% | -$1.5M+14.1% | -$1.3M+40.3% | $141K+101.5% | -$2.0M-74.6% |
| EPS (Basic) | -$0.27-170.0% | $0.13+244.4% | N/A | N/A | -$0.10+16.7% | -$0.09 | N/A | N/A |
| EPS (Diluted) | -$0.27-170.0% | $0.13+244.4% | N/A | -$0.12 | -$0.10 | -$0.09 | $0.00+100.0% | -$0.15 |
| Diluted Shares (Avg) | 15M+2.7% | 15M+4.4% | N/A | 15M | 14M | 14M | N/A | 14M |
Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.
INUV Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.3M-4.9% | $23.2M-26.7% | $24.9M-22.8% | $29.9M+3.2% | $28.7M+0.8% | $31.7M+6.4% | $32.2M-0.6% | $29.0M-19.9% |
| Current Assets | $7.3M-42.1% | $7.8M-48.8% | $9.2M-41.1% | $14.0M+14.4% | $12.5M+12.7% | $15.3M+26.0% | $15.6M+6.1% | $12.3M-32.3% |
| Cash & Equivalents | $886K-58.5% | $2.9M+12.7% | $2.8M+15.5% | $3.4M+30.6% | $2.1M+6.1% | $2.6M+28.1% | $2.5M-44.6% | $2.6M-63.0% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $4.5M-53.6% | $4.3M-64.0% | $5.9M-53.1% | $9.9M+13.1% | $9.7M+20.5% | $12.0M+38.0% | $12.5M+36.0% | $8.8M-13.6% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $9.9M0.0% | $9.9M0.0% | $9.9M0.0% | $9.9M0.0% | $9.9M0.0% | $9.9M0.0% | $9.9M0.0% | $9.9M0.0% |
| Total Liabilities | $19.0M+14.2% | $11.1M-39.3% | $14.8M-20.7% | $19.5M+17.6% | $16.6M+11.3% | $18.2M+24.4% | $18.7M+21.6% | $16.6M-4.2% |
| Current Liabilities | $12.1M-23.9% | $10.6M-39.5% | $14.3M-20.1% | $18.9M+20.4% | $15.9M+14.1% | $17.5M+28.2% | $17.9M+23.1% | $15.7M-4.6% |
| Non-Current Liabilities | $6.9M+888.0% | $498K-35.1% | $552K-33.9% | $625K-30.6% | $694K-28.6% | $767K-26.1% | $835K-2.8% | $901K+4.0% |
| Total Equity | $8.3M-31.1% | $12.2M-9.6% | $10.0M-25.6% | $10.4M-16.0% | $12.1M-10.8% | $13.4M-11.0% | $13.5M-20.7% | $12.4M-34.3% |
| Retained Earnings | -$180.4M-2.5% | -$176.4M-1.1% | -$178.3M-2.9% | -$177.7M-2.5% | -$176.0M-2.7% | -$174.5M-2.9% | -$173.2M-3.4% | -$173.4M-5.0% |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
INUV Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.3M-1706.1% | $1.6M+533.3% | $21K-93.6% | -$1.6M-249.5% | $144K-26.5% | -$367K+72.9% | $330K+115.7% | $1.1M-55.4% |
| Depreciation & Amortization | $519K-8.8% | $539K-5.2% | $549K-2.7% | $555K-9.5% | $569K-18.1% | $568K-15.6% | $564K-49.5% | $613K+39.2% |
| Stock-Based Compensation | $240K-17.6% | $303K-0.5% | N/A | $247K-33.7% | $292K-8.4% | $304K-23.2% | N/A | $373K-30.6% |
| Capital Expenditures | $239K-41.2% | $359K-20.5% | $361K-19.4% | $383K-19.6% | $407K-11.9% | $452K-4.3% | $448K+5.7% | $476K+12.5% |
| Free Cash Flow | -$2.5M-868.0% | $1.2M+250.4% | -$340K-188.8% | -$2.0M-436.7% | -$263K+1.2% | -$819K+55.2% | -$118K+95.3% | $584K-70.1% |
| Investing Cash Flow | -$239K+41.2% | -$359K+20.5% | -$361K+19.4% | -$383K+19.6% | -$407K+11.9% | -$452K+4.3% | -$448K-5.7% | -$476K-12.5% |
| Financing Cash Flow | $6.7M+4220.1% | -$1.2M-228.5% | -$200K-1925.5% | $3.2M+35381.8% | -$164K-6.5% | $921K+610.0% | -$10K+45.8% | -$9K+54.4% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
INUV Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.2%-31.2pp | 46.2%-32.7pp | 66.4%-16.7pp | 73.4%-15.0pp | 75.4%-8.6pp | 79.0%-8.7pp | 83.1%-4.2pp | 88.4%-2.3pp |
| Operating Margin | -40.4%-31.4pp | -49.0%-42.3pp | -8.5%-9.3pp | -7.4%+1.3pp | -9.0%+0.3pp | -6.6%+5.7pp | 0.8%+12.5pp | -8.7%-3.8pp |
| Net Margin | -53.6%-47.0pp | 23.9%+28.6pp | -4.2%-4.7pp | -7.7%+1.4pp | -6.6%+3.0pp | -4.7%+7.7pp | 0.5%+44.5pp | -9.1%-4.4pp |
| Return on Equity | -48.6%-36.1pp | 15.6%+25.0pp | -5.9%-7.0pp | -16.7%-0.2pp | -12.4%+0.5pp | -9.4%+4.6pp | 1.1%+55.0pp | -16.5%-10.3pp |
| Return on Assets | -14.8%-9.6pp | 8.2%+12.1pp | -2.4%-2.8pp | -5.8%+1.2pp | -5.2%+0.9pp | -4.0%+3.1pp | 0.4%+28.7pp | -7.0%-3.8pp |
| Current Ratio | 0.60-0.2x | 0.74-0.1x | 0.64-0.2x | 0.740.0x | 0.790.0x | 0.880.0x | 0.87-0.1x | 0.78-0.3x |
| Debt-to-Equity | 2.28+0.9x | 0.91-0.4x | 1.48+0.1x | 1.87+0.5x | 1.38+0.3x | 1.36+0.4x | 1.39+0.5x | 1.34+0.4x |
| Asset Turnover | 0.28-0.5x | 0.34-0.5x | 0.57-0.2x | 0.750.0x | 0.79+0.2x | 0.84+0.3x | 0.81+0.2x | 0.77+0.1x |
| FCF Margin | -33.8%-32.6pp | 15.5%+18.6pp | -2.4%-1.9pp | -8.7%-11.3pp | -1.2%+0.3pp | -3.1%+7.7pp | -0.4%+11.6pp | 2.6%-5.3pp |
Note: The current ratio is below 1.0 (0.64), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Inuvo, Inc. INUV | FY2025 | $86.2M | -$5.1M | -5.9% | $8.4M | 47/100 |
| Phunware, Inc. PHUN | FY2025 | $2.6M | -$11.4M | N/A | $42.4M | 50/100 |
| NetSol Technologies, Inc. NTWK | FY2026 | $78.1M | $3.0M | 3.8% | $74.8M | 63/100 |
| YXT.COM GROUP HOLDING LIMITED YXT | FY2025 | $48.7M | -$22.7M | -46.7% | $15.3M | 33/100 |
| Hitek Global Inc. HKIT | FY2025 | $6.5M | $180K | 2.8% | $21.7M | 50/100 |
Where Inuvo, Inc. Ranks
Frequently Asked Questions
What is Inuvo, Inc.'s annual revenue?
Inuvo, Inc. (INUV) reported $86.2M in total revenue for fiscal year 2025. This represents a 2.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Inuvo, Inc.'s revenue growing?
Inuvo, Inc. (INUV) revenue grew by 2.9% year-over-year, from $83.8M to $86.2M in fiscal year 2025.
Is Inuvo, Inc. profitable?
No, Inuvo, Inc. (INUV) reported a net income of -$5.1M in fiscal year 2025, with a net profit margin of -5.9%.
What is Inuvo, Inc.'s EBITDA?
Inuvo, Inc. (INUV) had EBITDA of -$4.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Inuvo, Inc.'s gross margin?
Inuvo, Inc. (INUV) had a gross margin of 74.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Inuvo, Inc.'s operating margin?
Inuvo, Inc. (INUV) had an operating margin of -7.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Inuvo, Inc.'s net profit margin?
Inuvo, Inc. (INUV) had a net profit margin of -5.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Inuvo, Inc.'s return on equity (ROE)?
Inuvo, Inc. (INUV) has a return on equity of -50.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Inuvo, Inc.'s free cash flow?
Inuvo, Inc. (INUV) recorded an outflow of $3.4M in free cash flow during fiscal year 2025. This represents a -108.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Inuvo, Inc.'s operating cash flow?
Inuvo, Inc. (INUV) recorded an outflow of $1.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Inuvo, Inc.'s total assets?
Inuvo, Inc. (INUV) had $24.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Inuvo, Inc.'s capital expenditures?
Inuvo, Inc. (INUV) invested $1.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Inuvo, Inc.'s current ratio?
Inuvo, Inc. (INUV) had a current ratio of 0.64 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Inuvo, Inc.'s debt-to-equity ratio?
Inuvo, Inc. (INUV) had a debt-to-equity ratio of 1.48 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Inuvo, Inc.'s return on assets (ROA)?
Inuvo, Inc. (INUV) had a return on assets of -20.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Inuvo, Inc.'s P/E ratio?
Inuvo, Inc. (INUV) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $8.4M as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Inuvo, Inc.'s price-to-sales ratio?
Inuvo, Inc. (INUV) trades at 0.2x sales, its market capitalization divided by revenue of $52.3M revenue, trailing 12 months to June 30, 2026. The market capitalization is $8.4M as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Inuvo, Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Inuvo, Inc. (INUV) held $2.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $1.8M over that year. Dividing the one by the other, the reported balance equals about 19 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Inuvo, Inc.'s Altman Z-Score?
Inuvo, Inc. (INUV) has an Altman Z-Score of -7.37, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Inuvo, Inc.'s Piotroski F-Score?
Inuvo, Inc. (INUV) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Inuvo, Inc.'s earnings high quality?
Inuvo, Inc. (INUV) reported a net loss of $5.1M while operations used $1.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Inuvo, Inc.?
Inuvo, Inc. (INUV) scores 47 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.